Literature DB >> 17404509

Hypoxia inducible factor-2alpha in cancer.

Tobias Löfstedt1, Erik Fredlund, Linda Holmquist-Mengelbier, Alexander Pietras, Marie Ovenberger, Lorenz Poellinger, Sven Påhlman.   

Abstract

Poorly oxygenated (hypoxic) tumors are frequently more aggressive compared to corresponding tumors that are better oxygenated. Adaptation to hypoxia is primarily mediated by two closely related hypoxia inducible transcription factor complexes, HIF-1 and HIF-2, which become stabilized and activated at low oxygen levels. Whether HIF-1 and HIF-2 have different roles in tumorigenesis is an open question and an issue we discuss. With focus on HIF-2, we summarize reported phenotypical changes of HIF genetic models and HIF expression patterns during normal development, in adult non-malignant tissues and in tumors. We further address the much-discussed subject of target gene preferences between HIF-1 and HIF-2, given that both transcription factors bind to the same DNA motif. Finally, we also discuss the observations that the oxygen-sensitive HIF-2alpha subunit is accumulated and active under non-hypoxic conditions as exemplified by HIF-2alpha expressing tumor macrophages and neuroblastoma cells located in seemingly well-vascularized tumor regions and how this phenomenon is related to tumor aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404509     DOI: 10.4161/cc.6.8.4133

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  65 in total

1.  Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.

Authors:  Changjun He; Xue-Pu Sun; Haiquan Qiao; Xian Jiang; Dongdong Wang; Xiangguo Jin; Xuesong Dong; Jizhou Wang; Hongchi Jiang; Xueying Sun
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.

Authors:  Yujuan Wang; Mones S Abu-Asab; Defen Shen; Zhengping Zhuang; Emily Y Chew; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-24       Impact factor: 3.117

3.  A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum.

Authors:  Heidi Rose Bokesch; Roberta Scott Gardella; Daniel Christopher Rabe; Donald Paul Bottaro; William Marston Linehan; James Brislin McMahon; Tawnya Carlene McKee
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

4.  RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha.

Authors:  Martijn van Hagen; René M Overmeer; Sharareh S Abolvardi; Alfred C O Vertegaal
Journal:  Nucleic Acids Res       Date:  2009-12-21       Impact factor: 16.971

Review 5.  Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2012-12-10       Impact factor: 9.867

6.  Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

Authors:  Sally K Martin; Peter Diamond; Sharon A Williams; Luen Bik To; Daniel J Peet; Nobutaka Fujii; Stan Gronthos; Adrian L Harris; Andrew C W Zannettino
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

7.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Authors:  Massimiliano Mazzone; Daniela Dettori; Rodrigo Leite de Oliveira; Sonja Loges; Thomas Schmidt; Bart Jonckx; Ya-Min Tian; Anthony A Lanahan; Patrick Pollard; Carmen Ruiz de Almodovar; Frederik De Smet; Stefan Vinckier; Julián Aragonés; Koen Debackere; Aernout Luttun; Sabine Wyns; Benedicte Jordan; Alberto Pisacane; Bernard Gallez; Maria Grazia Lampugnani; Elisabetta Dejana; Michael Simons; Peter Ratcliffe; Patrick Maxwell; Peter Carmeliet
Journal:  Cell       Date:  2009-02-12       Impact factor: 41.582

8.  Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha.

Authors:  Victoria Wang; David A Davis; Ravindra P Veeranna; Muzammel Haque; Robert Yarchoan
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

Review 9.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

Review 10.  Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

Authors:  K G Pringle; K L Kind; A N Sferruzzi-Perri; J G Thompson; C T Roberts
Journal:  Hum Reprod Update       Date:  2009-11-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.